Clinical Trials

Showing trials with last updates posted in 2024.

NCT03769467 | TERMINATED | PHASE1/PHASE2
12 participants

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Study Type:
INTERVENTIONAL
Last Updated:
2024-11-14
Start Date:
2019-02-19
Completion:
2021-08-19
Conditions
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms
  • Epstein-Barr Virus Infections
  • Epstein-Barr Viraemia
  • Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Interventions
  • BIOLOGICAL
NCT03357445 | ACTIVE_NOT_RECRUITING | NA
500 participants

AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2024-11-14
Start Date:
2011-10-14
Completion:
2027-04-27
Conditions
  • Primary Osteoarthritis
  • Post-Traumatic Arthritis
  • Inflammatory Joint Disease
  • Femoral Neck Fracture
  • Femoral Head Necrosis
  • Sequelae From Previous Hip Surgery
  • Osteotomies
  • Congenital Hip Dysplasia
Interventions
  • OTHER
No Results Yet
NCT03228043 | WITHDRAWN | NA
0 participants

Apatinib for Resectable Colorectal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-11-14
Start Date:
2020-03-01
Completion:
2021-03-01
Conditions
  • Apatinib
  • Outcome, Fatal
  • Colorectal Cancer
  • Surgery
  • Adjuvant Chemotherapy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page